Author

P. Huchede

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2

Frequent Co-Authors

A. Dutour· 3 shared J.-Y. Blay· 3 shared L. Broutier· 3 shared M. CASTETS· 3 shared M. Cordier-Bussat· 3 shared A. Bertrand-Chapel· 2 shared C. Degletagne· 2 shared C. Picard· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Dutour

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas

P. Huchede, S. Meyer, C. Berthelot, M. Hamadou, A. Bertrand-Chapel, A. Rakotomalala, L. MANCEAU, J. Tomine, N. Lespinasse, P. Lewandowski, M. Cordier-Bussat, L. Broutier, A. Dutour, I. Rochet, J.-Y. Blay, , C. MARIE

This study shows BMP2 and BMP7 work with H3.3K27M to create a quiescent yet invasive state in pediatric gliomas.

bioRxiv · Aug 9, 2023Cancer Biology

Alterations of the TGFb-sequestration complex member ADAMTSL1 levels are associated with muscular defects and rhabdomyosarcoma aggressiveness

A. Bertrand-Chapel, S. Meyer, G. Juban, A. E. M. Kneppers, P. Huchede, C. Gallerne, R. Benayoun, E. Cohen, A. Lopez-Gonzalez, S. B. Larbi, M. Creveaux, L. Vaille, A. Bouvier, M. Theodore, L. Broutier, , M. CASTETS

This study shows ADAMTSL1 is involved in skeletal muscle regeneration and acts as a prognostic factor in aggressive rhabdomyosarcoma, correlating with a neural-like phenotype.

bioRxiv · Mar 7, 2023 · PreprintCancer Biology

Fusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers

C. Savary, P. Huchede, L. Luciana, A. Tourbez, C. Deligne, C. Picard, T. Diot, C. Coquet, N. Meynard, M. Le Grand, L. Tonon, N. Gadot, C. Degletagne, S. Leon, V. Attignon, , L. Broutier

The paper develops a 3D-organoid model of fusion-negative rhabdomyosarcoma to predict resistance to cell death inducers using omics data.

bioRxiv · Sep 6, 2022 · PreprintCancer Biology

Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells via modulating metabolism and death pathways.

J. Vial, P. Huchede, S. Fagault, F. Basset, M. Rossi, J. Geoffray, J. Bisaccia, M. Creveaux, D. Neves, F. Fauvelle, P. Castets, M. Carre, K. Weber, M. Castets

This study shows that low ANT1 expression in rhabdomyosarcoma cells promotes oncogenic properties by altering metabolism and death pathways, and restoring ANT1 sensitizes cells to chemotherapy.

bioRxiv · Mar 3, 2020Cancer Biology